Average Co-Inventor Count = 5.69
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Wuhan University (10 from 263 patents)
2. Hubei Bio-pharmaceutical Industrial Technological Institute Inc. (3 from 5 patents)
3. Humanwell Healthcare (group) Co., Ltd. (3 from 4 patents)
4. Medshine Discovery Inc. (1 from 65 patents)
5. Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (1 from 1 patent)
6. Humanwell Healthcare Co., Ltd. (0 patent)
14 patents:
1. 12228601 - Single-ended fault positioning method and system for high-voltage direct-current transmission line of hybrid network
2. 12221449 - Pyrrolopyrimidine derivative and use thereof
3. 11966683 - Method and system for comprehensively evaluating reliability of multi-chip parallel IGBT module
4. 11953538 - Method and system for predicting insulated gate bipolar transistor lifetime based on compound failure mode coupling
5. 11913986 - Reliability evaluation method and system of microgrid inverter IGBT based on segmented LSTM
6. 11874640 - Wind power prediction method and system for optimizing deep transformer network
7. 11705899 - Serial IGBT voltage equalization method and system based on auxiliary voltage source
8. 11579644 - Method and system for online correction of junction temperatures of IGBT in photovoltaic inverter considering aging process
9. 11543446 - Multi-time-scale reliability evaluation method of wind power IGBT considering fatigue damage and system thereof
10. 11520676 - Method and system for power equipment diagnosis based on windowed feature and Hilbert visualization
11. 11378613 - IGBT module reliability evaluation method and device based on bonding wire degradation
12. 10941150 - Salt type and crystal type of 4h-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereof
13. 10428073 - Salt type and crystal type of 4H-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereof
14. 9856262 - Analogues of 4H-pyrazolo[1,5-a] benzimidazole compound as PARP inhibitors